Kevin Murphy

1.9k total citations · 1 hit paper
20 papers, 1.2k citations indexed

About

Kevin Murphy is a scholar working on Physiology, Psychiatry and Mental health and Oncology. According to data from OpenAlex, Kevin Murphy has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Physiology, 5 papers in Psychiatry and Mental health and 4 papers in Oncology. Recurrent topics in Kevin Murphy's work include Epilepsy research and treatment (5 papers), Asthma and respiratory diseases (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Kevin Murphy is often cited by papers focused on Epilepsy research and treatment (5 papers), Asthma and respiratory diseases (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Kevin Murphy collaborates with scholars based in Ireland, United States and United Kingdom. Kevin Murphy's co-authors include James Zangrilli, Philip G. Bardin, Mario Castro, Christopher O’Brien, Jorge Máspero, Michael E. Wechsler, Eric D. Bateman, Stephanie Korn, Guy Brusselle and Norman Delanty and has published in prestigious journals such as Blood, Bioinformatics and CHEST Journal.

In The Last Decade

Kevin Murphy

19 papers receiving 1.1k citations

Hit Papers

Reslizumab for inadequately controlled asthma with elevat... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin Murphy Ireland 11 813 574 243 201 198 20 1.2k
Jasper K W Gerritsen Netherlands 16 371 0.5× 219 0.4× 87 0.4× 71 0.4× 119 0.6× 27 848
Thomas Foiadelli Italy 19 150 0.2× 131 0.2× 52 0.2× 47 0.2× 69 0.3× 75 862
James G. Krings United States 9 342 0.4× 235 0.4× 101 0.4× 190 0.9× 98 0.5× 20 643
Linda Charles United States 15 84 0.1× 353 0.6× 194 0.8× 69 0.3× 64 0.3× 19 755
Maarten M. Boomsma Netherlands 11 282 0.3× 552 1.0× 130 0.5× 66 0.3× 45 0.2× 16 874
J Lacronique France 18 742 0.9× 681 1.2× 70 0.3× 132 0.7× 136 0.7× 42 1.2k
Laura Pini Italy 18 319 0.4× 441 0.8× 47 0.2× 57 0.3× 65 0.3× 67 828
Su‐Wei Chang Taiwan 12 177 0.2× 93 0.2× 73 0.3× 25 0.1× 61 0.3× 34 694
Maria Francesca Messina Italy 21 104 0.1× 74 0.1× 76 0.3× 191 1.0× 54 0.3× 63 1.0k
Christiane E.L. Dammann United States 22 39 0.0× 875 1.5× 60 0.2× 277 1.4× 41 0.2× 68 1.3k

Countries citing papers authored by Kevin Murphy

Since Specialization
Citations

This map shows the geographic impact of Kevin Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Murphy more than expected).

Fields of papers citing papers by Kevin Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Murphy. The network helps show where Kevin Murphy may publish in the future.

Co-authorship network of co-authors of Kevin Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Murphy. A scholar is included among the top collaborators of Kevin Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Murphy. Kevin Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mansoor, Salman, et al.. (2021). Natalizumab-associated progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS): “a case report from Ireland with review of literature, clinical pitfalls and future direction”. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 57(1). 7–7. 3 indexed citations
2.
Mansoor, Salman, et al.. (2020). Disulfiram induced bilateral foot drop; an under-recognised cause for peripheral neuropathy. Anaesthesia Pain & Intensive Care. 24(1). 108–110.
3.
Mansoor, Salman, et al.. (2020). Lentiform fork sign in a uremic patient with a high anion gap metabolic acidosis with seizures: a case report from North West of Ireland. The Egyptian Journal of Neurology Psychiatry and Neurosurgery. 56(1). 2 indexed citations
4.
Szefler, S.J., Jonathan A. Bernstein, Kevin Murphy, et al.. (2016). Efficacy of Tiotropium in Patients Aged 6-17 Years With Severe Symptomatic Asthma. CHEST Journal. 150(4). 969A–969A. 1 indexed citations
5.
Castro, Mario, James Zangrilli, Michael E. Wechsler, et al.. (2015). Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. The Lancet Respiratory Medicine. 3(5). 355–366. 840 indexed citations breakdown →
6.
Bernstein, David I., Kevin Murphy, & Hendrik Nolte. (2012). 188 Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects With Persistent Asthma. World Allergy Organization Journal. 5. S62–S62. 1 indexed citations
8.
Doherty, Colin P., Michael A. Farrell, M Fitzsimons, et al.. (2010). The Irish epilepsy surgery experience: Long-term follow-up. Seizure. 19(4). 247–252. 23 indexed citations
9.
Meltzer, Eli O., Michael S. Blaiss, Kevin Murphy, Robert A. Nathan, & Stuart Stoloff. (2010). The Asthma Insight and Management (AIM) Survey of Differences in Health Among Patients With Asthma and the General Population: Evidence of the Burden of Asthma. CHEST Journal. 138(4). 826A–826A. 1 indexed citations
10.
Murphy, Kevin, et al.. (2010). Formative evaluation of a telemedicine model for delivering clinical neurophysiology services part II: The referring clinician and patient perspective. BMC Medical Informatics and Decision Making. 10(1). 49–49. 12 indexed citations
12.
Ronan, Lisa, Cathy Scanlon, Kevin Murphy, et al.. (2010). Cortical curvature analysis in MRI-negative temporal lobe epilepsy: A surrogate marker for malformations of cortical development. Epilepsia. 52(1). 28–34. 16 indexed citations
13.
Murphy, Kevin, et al.. (2010). Formative evaluation of a telemedicine model for delivering clinical neurophysiology services part I: Utility, technical performance and service provider perspective. BMC Medical Informatics and Decision Making. 10(1). 48–48. 17 indexed citations
14.
Cheung, Matthew C., Lisa K. Hicks, Kevin Murphy, et al.. (2008). Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma. Blood. 112(11). 2587–2587. 1 indexed citations
15.
Ronan, Lisa, Kevin Murphy, Norman Delanty, et al.. (2007). Cerebral Cortical Gyrification: A Preliminary Investigation in Temporal Lobe Epilepsy. Epilepsia. 48(2). 211–219. 21 indexed citations
16.
McHugh, John C., et al.. (2007). Outcome Measurement after Vagal Nerve Stimulation Therapy: Proposal of a New Classification. Epilepsia. 48(2). 375–378. 109 indexed citations
17.
Shahwan, Amre, Kevin Murphy, Colin P. Doherty, et al.. (2006). The controversial association of ABCB1 polymorphisms in refractory epilepsy: An analysis of multiple SNPs in an Irish population. Epilepsy Research. 73(2). 192–198. 60 indexed citations
18.
Filipenko, Julie, Linda M. Vickars, Paul F. Galbraith, et al.. (2005). BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.. Blood. 106(11). 4674–4674. 1 indexed citations
19.
Murphy, Kevin, et al.. (2004). me-PCR: a refined ultrafast algorithm for identifying sequence-defined genomic elements. Bioinformatics. 20(4). 588–590. 12 indexed citations
20.
Murphy, Kevin & Norman Delanty. (2000). Primary generalized epilepsies. Current Treatment Options in Neurology. 2(6). 527–541. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026